Taiwanese researchers found that sodium benzoate, a metabolite of cinnamon, significantly improved cognitive function in individuals with mild Alzheimer's disease. In a 24-week trial, 750mg and 1000mg daily doses reduced amyloid plaques and improved cognitive scores, particularly in patients with initially higher amyloid-beta levels. The study, published in Translational Psychiatry, suggests sodium benzoate's potential as a safe and convenient Alzheimer's treatment, though further research is needed to confirm long-term effects and broader applicability.

Prepared by Olivia Bennett and reviewed by editorial team.